Becton, Dickinson and Company
Becton, Dickinson and Company BDX Peers
See (BDX) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BDX | $171.01 | +0.06% | 48.7B | 32.94 | $5.16 | +2.40% |
| ISRG | $542.65 | +4.03% | 191.5B | 78.24 | $6.83 | N/A |
| BDXA | $59.24 | -2.24% | 49.5B | 21.44 | $2.76 | +2.40% |
| ALC | $88.05 | +0.55% | 43.1B | 38.72 | $2.25 | +0.38% |
| RMD | $255.64 | -0.88% | 37.6B | 28.76 | $8.91 | +0.83% |
| WST | $218.96 | -0.93% | 15.7B | 34.44 | $6.36 | +0.38% |
| BAX | $30.41 | -0.67% | 15.7B | -58.67 | -$0.52 | +2.63% |
| HOLX | $65.48 | +1.88% | 14.5B | 27.36 | $2.38 | N/A |
| COO | $71.34 | +2.59% | 13.9B | 33.67 | $2.07 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +2.40% |
Stock Comparison
BDX vs ISRG Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, ISRG has a market cap of 191.5B. Regarding current trading prices, BDX is priced at $171.01, while ISRG trades at $542.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas ISRG's P/E ratio is 78.24. In terms of profitability, BDX's ROE is +0.06%, compared to ISRG's ROE of +0.16%. Regarding short-term risk, BDX is less volatile compared to ISRG. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs BDXA Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, BDXA has a market cap of 49.5B. Regarding current trading prices, BDX is priced at $171.01, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas BDXA's P/E ratio is 21.44. In terms of profitability, BDX's ROE is +0.06%, compared to BDXA's ROE of +0.06%. Regarding short-term risk, BDX is less volatile compared to BDXA. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs ALC Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, ALC has a market cap of 43.1B. Regarding current trading prices, BDX is priced at $171.01, while ALC trades at $88.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas ALC's P/E ratio is 38.72. In terms of profitability, BDX's ROE is +0.06%, compared to ALC's ROE of +0.07%. Regarding short-term risk, BDX is less volatile compared to ALC. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs RMD Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, RMD has a market cap of 37.6B. Regarding current trading prices, BDX is priced at $171.01, while RMD trades at $255.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas RMD's P/E ratio is 28.76. In terms of profitability, BDX's ROE is +0.06%, compared to RMD's ROE of +0.25%. Regarding short-term risk, BDX is less volatile compared to RMD. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs WST Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, WST has a market cap of 15.7B. Regarding current trading prices, BDX is priced at $171.01, while WST trades at $218.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas WST's P/E ratio is 34.44. In terms of profitability, BDX's ROE is +0.06%, compared to WST's ROE of +0.17%. Regarding short-term risk, BDX is less volatile compared to WST. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs BAX Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, BAX has a market cap of 15.7B. Regarding current trading prices, BDX is priced at $171.01, while BAX trades at $30.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas BAX's P/E ratio is -58.67. In terms of profitability, BDX's ROE is +0.06%, compared to BAX's ROE of -0.08%. Regarding short-term risk, BDX is more volatile compared to BAX. This indicates potentially higher risk in terms of short-term price fluctuations for BDX.
BDX vs HOLX Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, HOLX has a market cap of 14.5B. Regarding current trading prices, BDX is priced at $171.01, while HOLX trades at $65.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas HOLX's P/E ratio is 27.36. In terms of profitability, BDX's ROE is +0.06%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, BDX is less volatile compared to HOLX. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs COO Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, COO has a market cap of 13.9B. Regarding current trading prices, BDX is priced at $171.01, while COO trades at $71.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas COO's P/E ratio is 33.67. In terms of profitability, BDX's ROE is +0.06%, compared to COO's ROE of +0.05%. Regarding short-term risk, BDX is less volatile compared to COO. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs BDXB Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, BDX is priced at $171.01, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas BDXB's P/E ratio is 7.60. In terms of profitability, BDX's ROE is +0.06%, compared to BDXB's ROE of +0.06%. Regarding short-term risk, BDX is less volatile compared to BDXB. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs ATR Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, ATR has a market cap of 10.2B. Regarding current trading prices, BDX is priced at $171.01, while ATR trades at $155.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas ATR's P/E ratio is 28.24. In terms of profitability, BDX's ROE is +0.06%, compared to ATR's ROE of +0.15%. Regarding short-term risk, BDX is more volatile compared to ATR. This indicates potentially higher risk in terms of short-term price fluctuations for BDX.
BDX vs MASI Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, MASI has a market cap of 9B. Regarding current trading prices, BDX is priced at $171.01, while MASI trades at $168.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas MASI's P/E ratio is -30.48. In terms of profitability, BDX's ROE is +0.06%, compared to MASI's ROE of -0.41%. Regarding short-term risk, BDX is less volatile compared to MASI. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs RGEN Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, RGEN has a market cap of 7B. Regarding current trading prices, BDX is priced at $171.01, while RGEN trades at $123.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas RGEN's P/E ratio is -295.74. In terms of profitability, BDX's ROE is +0.06%, compared to RGEN's ROE of -0.01%. Regarding short-term risk, BDX is less volatile compared to RGEN. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs STVN Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, STVN has a market cap of 6.9B. Regarding current trading prices, BDX is priced at $171.01, while STVN trades at $24.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas STVN's P/E ratio is 47.44. In terms of profitability, BDX's ROE is +0.06%, compared to STVN's ROE of +0.09%. Regarding short-term risk, BDX is less volatile compared to STVN. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs MMSI Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, MMSI has a market cap of 5.5B. Regarding current trading prices, BDX is priced at $171.01, while MMSI trades at $93.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas MMSI's P/E ratio is 45.49. In terms of profitability, BDX's ROE is +0.06%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, BDX is more volatile compared to MMSI. This indicates potentially higher risk in terms of short-term price fluctuations for BDX.
BDX vs TFX Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, TFX has a market cap of 5.3B. Regarding current trading prices, BDX is priced at $171.01, while TFX trades at $119.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas TFX's P/E ratio is 37.00. In terms of profitability, BDX's ROE is +0.06%, compared to TFX's ROE of +0.03%. Regarding short-term risk, BDX is less volatile compared to TFX. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs BLCO Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, BLCO has a market cap of 4.3B. Regarding current trading prices, BDX is priced at $171.01, while BLCO trades at $12.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas BLCO's P/E ratio is -11.83. In terms of profitability, BDX's ROE is +0.06%, compared to BLCO's ROE of -0.08%. Regarding short-term risk, BDX is less volatile compared to BLCO. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs HAE Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, HAE has a market cap of 3.6B. Regarding current trading prices, BDX is priced at $171.01, while HAE trades at $74.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas HAE's P/E ratio is 22.61. In terms of profitability, BDX's ROE is +0.06%, compared to HAE's ROE of +0.18%. Regarding short-term risk, BDX is less volatile compared to HAE. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs ICUI Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, ICUI has a market cap of 3.2B. Regarding current trading prices, BDX is priced at $171.01, while ICUI trades at $130.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas ICUI's P/E ratio is -34.10. In terms of profitability, BDX's ROE is +0.06%, compared to ICUI's ROE of -0.05%. Regarding short-term risk, BDX is less volatile compared to ICUI. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs XRAY Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, XRAY has a market cap of 3.2B. Regarding current trading prices, BDX is priced at $171.01, while XRAY trades at $15.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas XRAY's P/E ratio is -3.58. In terms of profitability, BDX's ROE is +0.06%, compared to XRAY's ROE of -0.38%. Regarding short-term risk, BDX is less volatile compared to XRAY. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs WRBY Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, WRBY has a market cap of 2.6B. Regarding current trading prices, BDX is priced at $171.01, while WRBY trades at $21.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas WRBY's P/E ratio is -178.92. In terms of profitability, BDX's ROE is +0.06%, compared to WRBY's ROE of -0.04%. Regarding short-term risk, BDX is less volatile compared to WRBY. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs QDEL Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, QDEL has a market cap of 1.9B. Regarding current trading prices, BDX is priced at $171.01, while QDEL trades at $28.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas QDEL's P/E ratio is -5.49. In terms of profitability, BDX's ROE is +0.06%, compared to QDEL's ROE of -0.11%. Regarding short-term risk, BDX is less volatile compared to QDEL. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs NVCR Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, NVCR has a market cap of 1.9B. Regarding current trading prices, BDX is priced at $171.01, while NVCR trades at $17.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas NVCR's P/E ratio is -11.32. In terms of profitability, BDX's ROE is +0.06%, compared to NVCR's ROE of -0.45%. Regarding short-term risk, BDX is less volatile compared to NVCR. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs LMAT Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, LMAT has a market cap of 1.9B. Regarding current trading prices, BDX is priced at $171.01, while LMAT trades at $82.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas LMAT's P/E ratio is 41.83. In terms of profitability, BDX's ROE is +0.06%, compared to LMAT's ROE of +0.14%. Regarding short-term risk, BDX is less volatile compared to LMAT. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs ATRC Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, ATRC has a market cap of 1.6B. Regarding current trading prices, BDX is priced at $171.01, while ATRC trades at $32.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas ATRC's P/E ratio is -40.59. In terms of profitability, BDX's ROE is +0.06%, compared to ATRC's ROE of -0.08%. Regarding short-term risk, BDX is less volatile compared to ATRC. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs NNNN Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, NNNN has a market cap of 1.5B. Regarding current trading prices, BDX is priced at $171.01, while NNNN trades at $31.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas NNNN's P/E ratio is 672.80. In terms of profitability, BDX's ROE is +0.06%, compared to NNNN's ROE of +0.14%. Regarding short-term risk, BDX is less volatile compared to NNNN. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs AZTA Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, AZTA has a market cap of 1.4B. Regarding current trading prices, BDX is priced at $171.01, while AZTA trades at $29.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas AZTA's P/E ratio is -9.41. In terms of profitability, BDX's ROE is +0.06%, compared to AZTA's ROE of -0.04%. Regarding short-term risk, BDX is less volatile compared to AZTA. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs BLFS Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, BLFS has a market cap of 1B. Regarding current trading prices, BDX is priced at $171.01, while BLFS trades at $21.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas BLFS's P/E ratio is -113.05. In terms of profitability, BDX's ROE is +0.06%, compared to BLFS's ROE of -0.03%. Regarding short-term risk, BDX is less volatile compared to BLFS. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs PLSE Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, PLSE has a market cap of 1B. Regarding current trading prices, BDX is priced at $171.01, while PLSE trades at $15.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas PLSE's P/E ratio is -15.04. In terms of profitability, BDX's ROE is +0.06%, compared to PLSE's ROE of -0.71%. Regarding short-term risk, BDX is less volatile compared to PLSE. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs KMTS Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, KMTS has a market cap of 919.1M. Regarding current trading prices, BDX is priced at $171.01, while KMTS trades at $17.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas KMTS's P/E ratio is -9.32. In terms of profitability, BDX's ROE is +0.06%, compared to KMTS's ROE of +0.27%. Regarding short-term risk, BDX is less volatile compared to KMTS. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs STAA Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, STAA has a market cap of 833.5M. Regarding current trading prices, BDX is priced at $171.01, while STAA trades at $17.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas STAA's P/E ratio is -11.69. In terms of profitability, BDX's ROE is +0.06%, compared to STAA's ROE of -0.18%. Regarding short-term risk, BDX is less volatile compared to STAA. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs ATRI Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, BDX is priced at $171.01, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas ATRI's P/E ratio is 64.50. In terms of profitability, BDX's ROE is +0.06%, compared to ATRI's ROE of +0.04%. Regarding short-term risk, BDX is more volatile compared to ATRI. This indicates potentially higher risk in terms of short-term price fluctuations for BDX.
BDX vs ANGO Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, ANGO has a market cap of 400.8M. Regarding current trading prices, BDX is priced at $171.01, while ANGO trades at $9.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas ANGO's P/E ratio is -9.77. In terms of profitability, BDX's ROE is +0.06%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, BDX is less volatile compared to ANGO. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs NYXH Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, NYXH has a market cap of 287.5M. Regarding current trading prices, BDX is priced at $171.01, while NYXH trades at $7.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas NYXH's P/E ratio is -3.34. In terms of profitability, BDX's ROE is +0.06%, compared to NYXH's ROE of -0.56%. Regarding short-term risk, BDX is less volatile compared to NYXH. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs SMTI Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, SMTI has a market cap of 252.1M. Regarding current trading prices, BDX is priced at $171.01, while SMTI trades at $28.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas SMTI's P/E ratio is -21.16. In terms of profitability, BDX's ROE is +0.06%, compared to SMTI's ROE of -0.29%. Regarding short-term risk, BDX is less volatile compared to SMTI. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs OSUR Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, OSUR has a market cap of 225.9M. Regarding current trading prices, BDX is priced at $171.01, while OSUR trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas OSUR's P/E ratio is -7.19. In terms of profitability, BDX's ROE is +0.06%, compared to OSUR's ROE of -0.08%. Regarding short-term risk, BDX is less volatile compared to OSUR. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs STXS Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, STXS has a market cap of 188.3M. Regarding current trading prices, BDX is priced at $171.01, while STXS trades at $2.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas STXS's P/E ratio is -7.06. In terms of profitability, BDX's ROE is +0.06%, compared to STXS's ROE of -2.17%. Regarding short-term risk, BDX is less volatile compared to STXS. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs UTMD Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, UTMD has a market cap of 183.3M. Regarding current trading prices, BDX is priced at $171.01, while UTMD trades at $56.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas UTMD's P/E ratio is 14.89. In terms of profitability, BDX's ROE is +0.06%, compared to UTMD's ROE of +0.11%. Regarding short-term risk, BDX is less volatile compared to UTMD. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs KRMD Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, KRMD has a market cap of 165.2M. Regarding current trading prices, BDX is priced at $171.01, while KRMD trades at $3.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas KRMD's P/E ratio is -29.83. In terms of profitability, BDX's ROE is +0.06%, compared to KRMD's ROE of -0.30%. Regarding short-term risk, BDX is less volatile compared to KRMD. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs PDEX Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, PDEX has a market cap of 140.6M. Regarding current trading prices, BDX is priced at $171.01, while PDEX trades at $44.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas PDEX's P/E ratio is 15.62. In terms of profitability, BDX's ROE is +0.06%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, BDX is less volatile compared to PDEX. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs ZTEK Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, ZTEK has a market cap of 137.2M. Regarding current trading prices, BDX is priced at $171.01, while ZTEK trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas ZTEK's P/E ratio is -16.44. In terms of profitability, BDX's ROE is +0.06%, compared to ZTEK's ROE of -0.58%. Regarding short-term risk, BDX is less volatile compared to ZTEK. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs INFU Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, INFU has a market cap of 134.9M. Regarding current trading prices, BDX is priced at $171.01, while INFU trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas INFU's P/E ratio is 42.87. In terms of profitability, BDX's ROE is +0.06%, compared to INFU's ROE of +0.08%. Regarding short-term risk, BDX is less volatile compared to INFU. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs ZJYL Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, ZJYL has a market cap of 102.3M. Regarding current trading prices, BDX is priced at $171.01, while ZJYL trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas ZJYL's P/E ratio is 32.68. In terms of profitability, BDX's ROE is +0.06%, compared to ZJYL's ROE of +0.13%. Regarding short-term risk, BDX is less volatile compared to ZJYL. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs MBOT Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, MBOT has a market cap of 90.9M. Regarding current trading prices, BDX is priced at $171.01, while MBOT trades at $2.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas MBOT's P/E ratio is -3.91. In terms of profitability, BDX's ROE is +0.06%, compared to MBOT's ROE of -0.85%. Regarding short-term risk, BDX is less volatile compared to MBOT. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs AKYA Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, AKYA has a market cap of 66.2M. Regarding current trading prices, BDX is priced at $171.01, while AKYA trades at $1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas AKYA's P/E ratio is -1.38. In terms of profitability, BDX's ROE is +0.06%, compared to AKYA's ROE of -5.06%. Regarding short-term risk, BDX is less volatile compared to AKYA. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs MLSS Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, MLSS has a market cap of 56.8M. Regarding current trading prices, BDX is priced at $171.01, while MLSS trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas MLSS's P/E ratio is -12.07. In terms of profitability, BDX's ROE is +0.06%, compared to MLSS's ROE of -0.83%. Regarding short-term risk, BDX is less volatile compared to MLSS. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs OMIC Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, BDX is priced at $171.01, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas OMIC's P/E ratio is -0.58. In terms of profitability, BDX's ROE is +0.06%, compared to OMIC's ROE of -0.58%. Regarding short-term risk, BDX is more volatile compared to OMIC. This indicates potentially higher risk in terms of short-term price fluctuations for BDX.
BDX vs IGAP Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, BDX is priced at $171.01, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas IGAP's P/E ratio is -10.52. In terms of profitability, BDX's ROE is +0.06%, compared to IGAP's ROE of +3.93%. Regarding short-term risk, BDX is less volatile compared to IGAP. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs DXR Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, DXR has a market cap of 48.2M. Regarding current trading prices, BDX is priced at $171.01, while DXR trades at $9.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas DXR's P/E ratio is -108.00. In terms of profitability, BDX's ROE is +0.06%, compared to DXR's ROE of +0.02%. Regarding short-term risk, BDX is less volatile compared to DXR. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs NEPH Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, NEPH has a market cap of 44.9M. Regarding current trading prices, BDX is priced at $171.01, while NEPH trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas NEPH's P/E ratio is 53.00. In terms of profitability, BDX's ROE is +0.06%, compared to NEPH's ROE of +0.09%. Regarding short-term risk, BDX is less volatile compared to NEPH. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs POCI Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, POCI has a market cap of 35M. Regarding current trading prices, BDX is priced at $171.01, while POCI trades at $4.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas POCI's P/E ratio is -5.02. In terms of profitability, BDX's ROE is +0.06%, compared to POCI's ROE of -0.54%. Regarding short-term risk, BDX is less volatile compared to POCI. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs SDC Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, BDX is priced at $171.01, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas SDC's P/E ratio is -0.03. In terms of profitability, BDX's ROE is +0.06%, compared to SDC's ROE of -1.96%. Regarding short-term risk, BDX is less volatile compared to SDC. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs FEMY Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, FEMY has a market cap of 28.7M. Regarding current trading prices, BDX is priced at $171.01, while FEMY trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas FEMY's P/E ratio is -1.08. In terms of profitability, BDX's ROE is +0.06%, compared to FEMY's ROE of -3.92%. Regarding short-term risk, BDX is less volatile compared to FEMY. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs IVC Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, BDX is priced at $171.01, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas IVC's P/E ratio is -0.79. In terms of profitability, BDX's ROE is +0.06%, compared to IVC's ROE of -0.46%. Regarding short-term risk, BDX is less volatile compared to IVC. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs HBIO Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, HBIO has a market cap of 22.6M. Regarding current trading prices, BDX is priced at $171.01, while HBIO trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas HBIO's P/E ratio is -0.39. In terms of profitability, BDX's ROE is +0.06%, compared to HBIO's ROE of -1.10%. Regarding short-term risk, BDX is less volatile compared to HBIO. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs RVP Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, RVP has a market cap of 19.8M. Regarding current trading prices, BDX is priced at $171.01, while RVP trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas RVP's P/E ratio is -0.87. In terms of profitability, BDX's ROE is +0.06%, compared to RVP's ROE of -0.27%. Regarding short-term risk, BDX is less volatile compared to RVP. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs WOK Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, WOK has a market cap of 18.4M. Regarding current trading prices, BDX is priced at $171.01, while WOK trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas WOK's P/E ratio is -2.74. In terms of profitability, BDX's ROE is +0.06%, compared to WOK's ROE of -0.30%. Regarding short-term risk, BDX is less volatile compared to WOK. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs NXGL Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, NXGL has a market cap of 18.4M. Regarding current trading prices, BDX is priced at $171.01, while NXGL trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas NXGL's P/E ratio is -5.33. In terms of profitability, BDX's ROE is +0.06%, compared to NXGL's ROE of -0.63%. Regarding short-term risk, BDX is less volatile compared to NXGL. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs NXGLW Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, NXGLW has a market cap of 17.1M. Regarding current trading prices, BDX is priced at $171.01, while NXGLW trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas NXGLW's P/E ratio is -0.19. In terms of profitability, BDX's ROE is +0.06%, compared to NXGLW's ROE of -0.63%. Regarding short-term risk, BDX is less volatile compared to NXGLW. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs MHUA Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, MHUA has a market cap of 13.9M. Regarding current trading prices, BDX is priced at $171.01, while MHUA trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas MHUA's P/E ratio is 1.10. In terms of profitability, BDX's ROE is +0.06%, compared to MHUA's ROE of +0.09%. Regarding short-term risk, BDX is less volatile compared to MHUA. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs LUCYW Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, LUCYW has a market cap of 13.8M. Regarding current trading prices, BDX is priced at $171.01, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas LUCYW's P/E ratio is N/A. In terms of profitability, BDX's ROE is +0.06%, compared to LUCYW's ROE of -0.95%. Regarding short-term risk, BDX is less volatile compared to LUCYW. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs EKSO Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, EKSO has a market cap of 8.6M. Regarding current trading prices, BDX is priced at $171.01, while EKSO trades at $3.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas EKSO's P/E ratio is -0.50. In terms of profitability, BDX's ROE is +0.06%, compared to EKSO's ROE of -0.82%. Regarding short-term risk, BDX is less volatile compared to EKSO. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs POAI Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, POAI has a market cap of 7.7M. Regarding current trading prices, BDX is priced at $171.01, while POAI trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas POAI's P/E ratio is -0.60. In terms of profitability, BDX's ROE is +0.06%, compared to POAI's ROE of -5.91%. Regarding short-term risk, BDX is less volatile compared to POAI. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs LUCY Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, LUCY has a market cap of 6.3M. Regarding current trading prices, BDX is priced at $171.01, while LUCY trades at $2.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas LUCY's P/E ratio is 0.04. In terms of profitability, BDX's ROE is +0.06%, compared to LUCY's ROE of -0.95%. Regarding short-term risk, BDX is less volatile compared to LUCY. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs STSS Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, STSS has a market cap of 5.6M. Regarding current trading prices, BDX is priced at $171.01, while STSS trades at $5.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas STSS's P/E ratio is N/A. In terms of profitability, BDX's ROE is +0.06%, compared to STSS's ROE of -0.99%. Regarding short-term risk, BDX is less volatile compared to STSS. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs NSTG Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, BDX is priced at $171.01, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas NSTG's P/E ratio is -0.03. In terms of profitability, BDX's ROE is +0.06%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, BDX is less volatile compared to NSTG. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs GCTK Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, GCTK has a market cap of 3M. Regarding current trading prices, BDX is priced at $171.01, while GCTK trades at $6.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas GCTK's P/E ratio is N/A. In terms of profitability, BDX's ROE is +0.06%, compared to GCTK's ROE of +3.93%. Regarding short-term risk, BDX is less volatile compared to GCTK. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs GMVD Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, BDX is priced at $171.01, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas GMVD's P/E ratio is -0.01. In terms of profitability, BDX's ROE is +0.06%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, BDX is less volatile compared to GMVD. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs GMVDW Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, BDX is priced at $171.01, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas GMVDW's P/E ratio is N/A. In terms of profitability, BDX's ROE is +0.06%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, BDX is less volatile compared to GMVDW. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs AVGR Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, BDX is priced at $171.01, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas AVGR's P/E ratio is -0.05. In terms of profitability, BDX's ROE is +0.06%, compared to AVGR's ROE of -54.25%. Regarding short-term risk, BDX is less volatile compared to AVGR. This indicates potentially lower risk in terms of short-term price fluctuations for BDX.
BDX vs IIN Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, IIN has a market cap of 0. Regarding current trading prices, BDX is priced at $171.01, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas IIN's P/E ratio is 226.45. In terms of profitability, BDX's ROE is +0.06%, compared to IIN's ROE of -0.00%. Regarding short-term risk, BDX is more volatile compared to IIN. This indicates potentially higher risk in terms of short-term price fluctuations for BDX.
BDX vs LMNX Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, LMNX has a market cap of 0. Regarding current trading prices, BDX is priced at $171.01, while LMNX trades at $36.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas LMNX's P/E ratio is N/A. In terms of profitability, BDX's ROE is +0.06%, compared to LMNX's ROE of +0.03%. Regarding short-term risk, BDX is more volatile compared to LMNX. This indicates potentially higher risk in terms of short-term price fluctuations for BDX.
BDX vs ATRS Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, ATRS has a market cap of 0. Regarding current trading prices, BDX is priced at $171.01, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas ATRS's P/E ratio is 14.95. In terms of profitability, BDX's ROE is +0.06%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, BDX is more volatile compared to ATRS. This indicates potentially higher risk in terms of short-term price fluctuations for BDX.
BDX vs APR Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, APR has a market cap of 0. Regarding current trading prices, BDX is priced at $171.01, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas APR's P/E ratio is 22.59. In terms of profitability, BDX's ROE is +0.06%, compared to APR's ROE of +9.81%. Regarding short-term risk, BDX is more volatile compared to APR. This indicates potentially higher risk in terms of short-term price fluctuations for BDX.
BDX vs HRC Comparison
BDX plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BDX stands at 48.7B. In comparison, HRC has a market cap of 0. Regarding current trading prices, BDX is priced at $171.01, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BDX currently has a P/E ratio of 32.94, whereas HRC's P/E ratio is 41.92. In terms of profitability, BDX's ROE is +0.06%, compared to HRC's ROE of +0.14%. Regarding short-term risk, BDX is more volatile compared to HRC. This indicates potentially higher risk in terms of short-term price fluctuations for BDX.